Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis, Mark Sorin, Connor Prosty, Louis Ghaleb, et al.
Proton Therapy Toxicity Outcomes for Localized Prostate Cancer: Long-Term Results at a Comprehensive Cancer Center, Alan J Sosa, Michael K Rooney, Howard D Thames, et al.
Nasal Bots Carry Relevant Titers of CWD Prions in Naturally Infected White-Tailed Deer, Paulina Soto, Francisca Bravo-Risi, Carlos Kramm, et al.
Daratumumab for Patients With Myeloma With Early or Late Relapse After Initial Therapy: Subgroup Analysis of Castor and Pollux, Andrew Spencer, Philippe Moreau, Maria-Victoria Mateos, et al.
Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials, Akanksha Srivastava, Graciela M Nogueras-Gonzalez, Yimin Geng, et al.
Abnormality of Early White Matter Development in Tuberous Sclerosis Complex and Autism Spectrum Disorder: Longitudinal Analysis of Diffusion Tensor Imaging Measures, Siddharth Srivastava, Fanghan Yang, Anna K Prohl, et al.
Exploring the PDZ, DUF, and LIM Domains of Pdlim5 in Dendrite Branching, Yogesh Srivastava, Maxsam Donta, Lydia L Mireles, et al.
Role of a PDLIM5:Palmd Complex in Directing Dendrite Morphology, Yogesh Srivastava, Maxsam Donta, Lydia L Mireles, et al.
Targeting Prostate Tumor Low-Molecular Weight Tyrosine Phosphatase for Oxidation-Sensitizing Therapy, Stephanie M Stanford, Tiffany P Nguyen, Joseph Chang, et al.
Current and Future Therapeutic Strategies for High-Grade Gliomas Leveraging the Interplay Between Epigenetic Regulators and Kinase Signaling Networks, Lea M Stitzlein, Jack T Adams, Erin N Stitzlein, et al.
High-Density Glass Scintillators for Proton Radiography-Relative Luminosity, Proton Response, and Spatial Resolution, Ethan Stolen, Ryan Fullarton, Rain Hein, et al.
Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia, Lincoln N Strickland, Wendao Liu, Usama Hussein, et al.
Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies, Vivek Subbiah, Niamh Coleman, Sarina A Piha-Paul, et al.
Adaptive Darwinian Off-Target Resistance Mechanisms to Selective RET Inhibition in RET Driven Cancer., Vivek Subbiah, Mohamed A Gouda, J Bryan Iorgulescu, et al.
Lifestyle Medicine for the Prevention and Treatment of Pancreatitis and Pancreatic Cancer, Sruthi Kapliyil Subramanian, Bhaumik Brahmbhatt, Jennifer M Bailey-Lundberg, et al.
Enhancing NSCLC Recurrence Prediction With PET/CT Habitat Imaging, ctDNA, and Integrative Radiogenomics-Blood Insights, Sheeba J Sujit, Muhammad Aminu, Tatiana V Karpinets, et al.
Neoantigen-Specific Cytotoxic TR1 CD4 T Cells Suppress Cancer Immunotherapy, Hussein Sultan, Yoshiko Takeuchi, Jeffrey P Ward, et al.
Bispecific BCMA/CD24 Car-T Cells Control Multiple Myeloma Growth, Fumou Sun, Yan Cheng, Visanu Wanchai, et al.
A Deep Catalogue of Protein-Coding Variation in 983,578 Individuals, Kathie Y Sun, Xiaodong Bai, Siying Chen, et al.
Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications, Xiaoqi Sun, Xuehui Huang, Kyung Soo Park, et al.
A Spatiotemporal Map of Co-Receptor Signaling Networks Underlying B Cell Activation, Katherine J Susa, Gary A Bradshaw, Robyn J Eisert, et al.
RAD21 Promotes Oncogenesis and Lethal Progression of Prostate Cancer, Xiaofeng A Su, Konrad H Stopsack, Daniel R Schmidt, et al.
Genetic Drivers of Heterogeneity in Type 2 Diabetes Pathophysiology, Ken Suzuki, Konstantinos Hatzikotoulas, Lorraine Southam, et al.
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors, Christopher J Sweeney, John D Hainsworth, Ron Bose, et al.
Personalized Neoantigen Vaccines As Early Intervention in Untreated Patients With Lymphoplasmacytic Lymphoma: A Non-Randomized Phase 1 Trial, Szymon J Szymura, Lin Wang, Tiantian Zhang, et al.